Recent Finacing
Recent Raise
BOOST Pharma is a Stockholm-based clinical-stage biopharmaceutical company developing BT-101, a stem-cell therapy for children with the rare genetic bone disorder osteogenesis imperfecta (OI).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at BOOST Pharma.
